Pharmaceuticals

SCI SCIE

国际简称：PHARMACEUTICALS-BASE 参考译名：药品

主要研究方向：Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science 非预警期刊审稿周期：6 Weeks

《药品》(Pharmaceuticals)是一本由Multidisciplinary Digital Publishing Institute (MDPI)出版的以Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
1919 年发文量
5.7 IF影响因子
开放是否OA
2004 创刊年份
12 issues/year 出版周期
English 出版语言

Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences.

[ 查看全部 ]

投稿咨询加急咨询

Pharmaceuticals期刊信息

ISSN：1424-8247
出版语言：English
是否OA：开放
E-ISSN：1424-8247
出版地区：SWITZERLAND
是否预警：否
出版商：Multidisciplinary Digital Publishing Institute (MDPI)
出版周期：12 issues/year
创刊时间：2004
开源占比：0.9947
Gold OA文章占比：99.96%
OA被引用占比：1
出版国人文章占比：0.01
出版撤稿占比：0
研究类文章占比：70.30%

Pharmaceuticals CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

1.14

1.313

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q1	29 / 191	85%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery	Q1	29 / 161	82%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Molecular Medicine	Q1	39 / 179	78%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Pharmaceuticals中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学	2区 2区

Pharmaceuticals JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CHEMISTRY, MEDICINAL	SCIE	Q1	16 / 72	78.5
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	52 / 356	85.5
学科：CHEMISTRY, MEDICINAL	SCIE	Q1	17 / 72	77.08
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	74 / 356	79.35

Pharmaceuticals历年数据统计

影响因子

中科院分区

Pharmaceuticals中国学者发文选摘

1、Targeting the Ras-Ral Signaling Axis in Type 2 Diabetes Mellitus: A Dual-Modulation Approach to Correcting Insulin Resistance and β-Cell Dysfunctio
Author: Thulasi, Narayanan; Harithpriya, Kannan; Ganesan, Kumar; Ramkumar, Kunka Mohanram

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040648
2、Short Peptide with Sequence of LAGAAHF, Identified from Edible Bird's Nest, Reduces Dermatitis Symptoms in Mic
Author: Lai, Queenie Wing Sze; Wang, Yaxin; Lin, Shengying; Yuen, Gary Ka Wing; Ospondpant, Dusadee; Gao, Alex Xiong; Dong, Tina Ting Xia; Liu, Xuncai; Fan, Qunyan; Tsim, Karl Wah Keung

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040649
3、RETRACTION: Adenine Inhibits the Invasive Potential of DLD-1 Human Colorectal Cancer Cell via the AMPK/FAK Axi
Author: Huang, Chien-Wei; Lin, You-Cian; Hung, Chia-Hung; Chen, Han-Min; Lin, Jiun-Tsai; Wang, Chau-Jong; Kao, Shao-Hsuan

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040646
4、Artemisia argyi Levl.et Vant Extract (AALE) and Parthenolide Suppress Respiratory Syncytial Virus (RSV) via the RIG-I/TLR3 Pathway In Vivo and In Vitr
Author: Tan, Zeting; Liang, Rongshun; Junka, Adam; Sun, Haoxuan; Jiang, Jie; Ma, Haojia; Fang, Shisong; Sun, Yanfang

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040640
5、Inflammation-Driven JNK Activation Promotes EMT and Metastasis in Gastric Cancer and Is Attenuated by Huangjin Shuangshen Granule
Author: Zhang, Shuo; Huang, Chen; Song, Zhiyuan; Lou, Jiaheng; Zhang, Jingcheng; Zhao, Sicheng; Jiang, Tao; Zhang, Guangji

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040636
6、(5R)-5-Hydroxytriptolide (LLDT-8) Ameliorates Experimental Autoimmune Myositis via Suppression of the NLRC5/MHC-I Signaling Pathwa
Author: Hao, Tingting; Qi, Qing; Xie, Cancan; Chen, Li; Shao, Meijuan; Wang, Que; Lin, Zemin; Zhu, Fenghua; Yang, Xiaoqian; He, Shijun; Zuo, Jianping

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040631
7、Mechanism of Bao Jing Tablets in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Insights from Multi-Omics and Network Pharmacolog
Author: Ge, Haitao; Zhang, Yan; Jin, Siqi; Wang, Chen; Wang, Fujiang

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040632
8、Development of Pseudoginsenoside RT2 as a Novel Gut-Selective Agent: Integrated Pharmacodynamic and Pharmacokinetic Evaluation of an Ocotillol Ginsenoside for Ulcerative Coliti
Author: Li, Zhuoqiao; Wu, Junzhe; Wang, Jia; Liu, Yuwei; Liu, Linxuan; Wang, Yiyuan; Bu, Yanbo; Geng, Xiaoyu; Liu, Jinping

Journal: PHARMACEUTICALS. 2026; Vol. 19, Issue 4, pp. -. DOI: 10.3390/ph19040622